Literature DB >> 21918900

Pattern of bone mineral density in idiopathic male osteoporosis.

Michel Laroche1.   

Abstract

The mechanisms of male idiopathic osteoporosis are little known. We evaluated bone mineral loss by dual-energy X-ray absorptiometry and determined its cortical or trabecular nature in a cohort of men with idiopathic osteoporosis with fractures. Thirty-nine men (mean age 60 ± 13 years), with negative investigations for the cause of osteoporosis, were studied. All had fragility fractures: vertebral 51%, peripheral 25%, and both types 24%. Bone density was measured at the lumbar spine (L2-L4), total hip and whole body. The limb/axial skeleton (spine + hips) and hip/L2-L4 BMD ratios were calculated. Serum 25-hydroxy-vitamin D, PTH, bone alkaline phosphatase and CTX were measured. Bone mineral loss predominated at the lumbar spine (mean L2-L4 T-score -3 ± 0.93, mean total hip T-score -1.87 ± 0.75). Limb/axial skeleton and total hip/L2-L4 BMD were strongly correlated, but not hip and spine BMD. The ratio values were widely scattered, indicating markedly heterogeneous bone loss. Vitamin D, PTH, bone alkaline phosphatase and CTX levels did not differ between predominantly trabecular and cortical osteoporosis. Bone mineral density measurement in male idiopathic osteoporosis with fractures demonstrated that bone loss predominated in the spine and that it was very heterogeneous, principally affecting cortical or trabecular bone depending on the patient.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21918900     DOI: 10.1007/s00296-011-2076-7

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  24 in total

1.  Osteoporosis assessment by whole body region vs. site-specific DXA.

Authors:  L Joseph Melton; Anne C Looker; John A Shepherd; Michael K O'Connor; Sara J Achenbach; B Lawrence Riggs; Sundeep Khosla
Journal:  Osteoporos Int       Date:  2005-04-06       Impact factor: 4.507

Review 2.  Clinical practice. Osteoporosis in men.

Authors:  Peter R Ebeling
Journal:  N Engl J Med       Date:  2008-04-03       Impact factor: 91.245

Review 3.  Bone fragility in men--where are we?

Authors:  E Seeman; G Bianchi; S Khosla; J A Kanis; E Orwoll
Journal:  Osteoporos Int       Date:  2006-08-01       Impact factor: 4.507

4.  Primary hyperparathyroidism: biochemical markers and bone mineral density at multiple skeletal sites in Danish patients.

Authors:  P Christiansen; T Steiniche; K Brixen; I Hessov; F Melsen; P Charles; L Mosekilde
Journal:  Bone       Date:  1997-07       Impact factor: 4.398

Review 5.  Unresolved issues in osteoporosis in men.

Authors:  E Seeman
Journal:  Rev Endocr Metab Disord       Date:  2001-01       Impact factor: 6.514

6.  Smoking is associated with lower bone mineral density and reduced cortical thickness in young men.

Authors:  Mattias Lorentzon; Dan Mellström; Egil Haug; Claes Ohlsson
Journal:  J Clin Endocrinol Metab       Date:  2006-10-31       Impact factor: 5.958

7.  Bone mass in middle-aged osteoporotic men and their relatives: familial effect.

Authors:  M E Cohen-Solal; C Baudoin; M Omouri; D Kuntz; M C De Vernejoul
Journal:  J Bone Miner Res       Date:  1998-12       Impact factor: 6.741

8.  Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures.

Authors:  D Marshall; O Johnell; H Wedel
Journal:  BMJ       Date:  1996-05-18

9.  Bone histomorphometry in men with spinal osteoporosis.

Authors:  H K Delichatsios; J M Lane; R S Rivlin
Journal:  Calcif Tissue Int       Date:  1995-05       Impact factor: 4.333

10.  Bone histomorphometry in male idiopathic osteoporosis.

Authors:  Ylva Pernow; Ellen M Hauge; Kristina Linder; Eilif Dahl; Maria Sääf
Journal:  Calcif Tissue Int       Date:  2009-03-24       Impact factor: 4.333

View more
  1 in total

1.  Genetic determinants of trabecular and cortical volumetric bone mineral densities and bone microstructure.

Authors:  Lavinia Paternoster; Mattias Lorentzon; Terho Lehtimäki; Joel Eriksson; Mika Kähönen; Olli Raitakari; Marika Laaksonen; Harri Sievänen; Jorma Viikari; Leo-Pekka Lyytikäinen; Dan Mellström; Magnus Karlsson; Osten Ljunggren; Elin Grundberg; John P Kemp; Adrian Sayers; Maria Nethander; David M Evans; Liesbeth Vandenput; Jon H Tobias; Claes Ohlsson
Journal:  PLoS Genet       Date:  2013-02-21       Impact factor: 5.917

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.